Next, we delved into the impact of PI3Kδ and IFNγR expression on patient prognosis and the response to ICB treatment by leveraging the Tumor Immunotherapy Gene Expression Resource (TIGER) database. This evidence concerns the gene IFNGR1 and neoplasm.